IP Library Granted Patent US 7,850,989
Granted Patent B2
US 7,850,989 · App. 10/702,406 · Granted Dec 14, 2010

Critical care for neonatal calves

Assignee: Provimi North America, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,850,989
App. No.
10/702,406
Granted
Dec 14, 2010
Kind
B2
Abstract

A product and method for treating dehydration in neonatal calves. The product is administered to dehydrated calves during treatment, to the exclusion of milk replacers or electrolytes.

Claims (20)

1. A method for treating or reducing the likelihood of dehydration in a neonatal bovine mammal, said method comprising the steps of:

providing a physiological composition comprising a source of nutrients, said nutrients including in an effective amount to treat or reduce the likelihood of dehydration in said neonatal bovine mammal;

administering to said neonatal bovine mammal said physiological composition wherein said source of nutrients comprises crude protein from a milk protein source and electrolytes, wherein said nutrients include dextrans having at least two different saccharides; and

said dextrans including a majority of maltodextrins relative to any other saccharide therein;

providing enough energy and protein to maintain a body weight and growth of said neonatal bovine mammal;

wherein an amount of said dextrans is greater than an amount of any other of said nutrients.

2. The method of claim 1 , wherein said source of nutrients are prepackaged in a sealed container, said method further comprising the step of rehydrating said physiological composition from said prepackaged source of nutrients prior to administering said composition to said neonatal bovine mammal.

3. The method of claim 2 , wherein said step of rehydrating said physiological composition comprises adding about 0.45 to 0.55 pounds of said physiological composition to about two quarts of water.

4. The method of claim 3 , wherein said physiological composition is added to about one quart of water to form a first solution and said first solution is subsequently diluted with about one quart of water to form a second solution, said second solution being administered to said neonatal bovine mammal about three or more times in a 24-hour period.

5. The method of claim 1 , wherein said source of nutrients comprises:

about 50 to 60% dextrans;

about 10 to 20% bicarbonate of soda;

about 1 to 10% sodium; and

about 1 to 10% potassium.

6. The method of claim 5 , wherein said dextrans includes a mixture of maltodextrins and dextrose.

7. The method of claim 6 , wherein said mixture of maltodextrins and dextrose includes about 35 to 45% maltodextrins and about 10 to 20% dextrose.

8. The method of claim 1 , further comprising at least one agent selected from the group consisting of whey protein concentrate, microbial blend, emulsifier, or anti-caking agent, and one or more amino acids, artificial flavors, or vitamins.

9. The method of claim 1 , wherein said neonatal bovine mammal is a calf.

10. The method of claim 9 , wherein said calf is about three months of age or less.

11. The method of claim 2 , wherein said source of nutrients are sealed together in a single container.

Assignments (4)
RELEASE OF INTELLECTUAL PROPERTY Recorded Nov 29, 2011
From: THE ROYAL BANK OF SCOTLAND N.V., AS SECURITY TRUSTEE
To: PROVIMI NORTH AMERICA, INC.
Reel/Frame 027289/0739 →
CHANGE OF NAME Recorded Jun 17, 2010
From: NORTH AMERICAN NUTRITION COMPANIES, INC.
To: PROVIMI NORTH AMERICA, INC.
Reel/Frame 024551/0124 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 30, 2007
From: NORTH AMERICAN NUTRITION COMPANIES, INC.
To: ABN AMRO BANK N.V.
Reel/Frame 020184/0621 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2004
From: HILL, T. MARK
To: NORTH AMERICAN NUTRITION COMPANIES, INC.
Reel/Frame 015602/0441 →
Continuity (2)
Provisional Application 6047782700 · Jun 12, 2003
Related Publication 20040253324A1 · Dec 16, 2004